Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods

Scand J Clin Lab Invest. 2015 Sep;75(5):355-61. doi: 10.3109/00365513.2015.1030765. Epub 2015 Apr 9.

Abstract

Objective: Faecal (f-) calprotectin is a widely used surrogate marker of intestinal inflammation. F-calprotectin analysis is labour demanding partly due to a time consuming extraction step. The aim of this project was to validate a new extraction method for f-calprotectin.

Material and methods: A prospective multicentre study included 135 patients with an established diagnosis of inflammatory bowel disease. The patients submitted a faeces sample, which was extracted with both the conventional method at the participating laboratory and the new extraction device. The extracts were analyzed by an automated ELISA instrument.

Results: Method comparison of the traditional method and the new device showed a slope of 1.01 (0.93-1.07) with intercept of - 2.2 (- 4.9-0.6). The Spearman rank correlation coefficient was 0.96.

Conclusions: The new extraction device is a reliable and time saving alternative to the conventional extraction method.

Keywords: Biological markers; Crohn disease; colitis; enzyme-linked immunosorbent assay; faeces; inflammatory bowel disease; leukocyte L1 antigen complex; ulcerative.

Publication types

  • Comparative Study
  • Multicenter Study
  • Validation Study

MeSH terms

  • Adult
  • Enzyme-Linked Immunosorbent Assay / instrumentation*
  • Feces / chemistry*
  • Female
  • Humans
  • Inflammatory Bowel Diseases / diagnosis*
  • Intestinal Mucosa / pathology
  • Leukocyte L1 Antigen Complex / analysis*
  • Male
  • Regression Analysis
  • Statistics, Nonparametric
  • Wound Healing

Substances

  • Leukocyte L1 Antigen Complex